Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Botulinum toxin type A 50unit inj vials
0409030B0AAADAD
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | 1 |
|
Buprenorphine 5.7mg / Naloxone 1.4mg SL tab sugar free
0410030B0AAAIAI
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 1 |
|
Carbagen 100mg tablets
0408010C0BFACAB
|
Carbagen | Carbamazepine | Central Nervous System | 1 |
|
Carbamazepine 120mg/5ml oral liquid
0408010C0AABFBF
|
Carbamazepine | Carbamazepine | Central Nervous System | 1 |
|
Carexil 10mg modified-release tablets
0407020ADBDABAF
|
Carexil | Oxycodone hydrochloride | Central Nervous System | 1 |
|
Chlorpromazine 10mg capsules
0402010D0AABDBD
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | 1 |
|
Clobazam 500micrograms/5ml oral liquid
040801060AACDCD
|
Clobazam | Clobazam | Central Nervous System | 1 |
|
Clonazepam 50micrograms/5ml oral liquid
0408010F0AABZBZ
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | 1 |
|
Clonidine 125micrograms/5ml oral liquid
0407042F0AAARAR
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Clonidine 250micrograms/5ml oral solution
0407042F0AAAVAV
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Clonidine 25micrograms/5ml oral liquid
0407042F0AAAGAG
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Clonidine 3.75micrograms/5ml oral suspension
0407042F0AAAYAY
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Clotam Rapid 200mg tablets
0407041U0BBABAB
|
Clotam | Tolfenamic acid | Central Nervous System | 1 |
|
Clozapine 100mg orodispersible tablets sugar free
0402010C0AAAKAK
|
Clozapine | Clozapine | Central Nervous System | 1 |
|
Clozapine 12.5mg orodispersible tablets sugar free
0402010C0AAAHAH
|
Clozapine | Clozapine | Central Nervous System | 1 |
|
Co-proxamol 32.5mg/325mg/5ml oral suspension
0407010Q0AAADAD
|
Co-proxamol | Co-proxamol (Dextropropoxyphene hydrochloride/paracetamol) | Central Nervous System | 1 |
|
Codis 500 dispersible tablets
0407010W0BHAAAD
|
Codis | Aspirin combined preparations | Central Nervous System | 1 |
|
Covonia Cold & Flu Formula oral solution
0407010X0CKAABJ
|
Covonia (Paracetamol combined) | Paracetamol combined preparations | Central Nervous System | 1 |
|
Cyclizine 25mg suppositories
0406000F0AAAEAE
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | 1 |
|
Cyclizine 5mg/5ml oral liquid
0406000F0AABBBB
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | 1 |
|
Depixol Conc 50mg/0.5ml solution for injection ampoules
0402020G0BBAFAH
|
Depixol (Parenteral) | Flupentixol decanoate | Central Nervous System | 1 |
|
Desitrend 100mg/ml oral solution
0408010A0BDADAH
|
Desitrend | Levetiracetam | Central Nervous System | 1 |
|
Diamorphine 5mg powder for solution for injection vials
0407020K0AAEFEF
|
Diamorphine hydrochloride (Systemic) | Diamorphine hydrochloride (Systemic) | Central Nervous System | 1 |
|
Disulfiram 500mg tablets
0410010B0AAAEAE
|
Disulfiram | Disulfiram | Central Nervous System | 1 |
|
Duodopa intestinal gel 100ml cassette
0409010N0BDAAAR
|
Duodopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.